OTCMKTS:PBIO Pressure BioSciences (PBIO) Stock Price, News & Analysis → Urgent Nvidia Warning (From Altimetry) (Ad) Free PBIO Stock Alerts $0.22 -0.03 (-11.95%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$0.20▼$0.2550-Day Range$0.14▼$0.3052-Week Range$0.14▼$1.04Volume28,000 shsAverage Volume34,959 shsMarket Capitalization$7.43 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get Pressure BioSciences alerts: Email Address Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. About Pressure BioSciences Stock (OTCMKTS:PBIO)Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and the Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. and changed its name to Pressure BioSciences, Inc. in September 2014. The company was incorporated in 1978 and is based in South Easton, Massachusetts.Read More PBIO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PBIO Stock News HeadlinesMay 3, 2024 | americanbankingnews.comPressure BioSciences (OTCMKTS:PBIO) Share Price Passes Below 200 Day Moving Average of $0.34April 24, 2024 | bbc.co.ukThe big blood pressure experimentMay 4, 2024 | Porter & Company (Ad)Elon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.April 24, 2024 | americanbankingnews.comPressure BioSciences (OTCMKTS:PBIO) Shares Pass Below Two Hundred Day Moving Average of $0.34April 22, 2024 | msn.comPacBio moved to Neutral at JPMorgan after guidance cutApril 2, 2024 | finance.yahoo.comPressure BioSciences’ Uncle Bud’s Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New “Premium Collection”April 2, 2024 | globenewswire.comPressure BioSciences' Uncle Bud's Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New “Premium Collection”March 25, 2024 | nytimes.comThe Best Pressure WasherMay 4, 2024 | Porter & Company (Ad)Elon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.March 5, 2024 | nypost.comThe 8 best blood pressure monitors, approved by expertsFebruary 26, 2024 | globenewswire.comUncle Bud's Health & Wellness Experiencing Powerful Growth One Month Following Acquisition by Pressure BioSciences, Inc.February 23, 2024 | benzinga.comPressure BioSciences Stock (OTC:PBIO) Insider TradesFebruary 15, 2024 | finance.yahoo.comPressure BioSciences Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract ManufacturingFebruary 15, 2024 | globenewswire.comPressure BioSciences Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract ManufacturingFebruary 6, 2024 | forbes.comWrist Blood Pressure Monitors: Are They Accurate?February 5, 2024 | forbes.comBest Blood Pressure Monitors For 2024February 5, 2024 | finance.yahoo.comUncle Bud’s to Launch New Premium Health and Wellness Products Leveraging Pressure BioSciences UltraShear Processing for Revolutionary Product EffectivenessJanuary 26, 2024 | msn.comPressure Biosciences Acquires Uncle Bud’s AssetsJanuary 22, 2024 | finance.yahoo.comPressure BioSciences Announces Closing of Uncle Bud’s Acquisition in All-Stock Transaction, Completing UltraShear Nanoemulsions Forward Integration with World Class Marketing & SalesJanuary 20, 2024 | benzinga.comPressure BioSciences Stock (OTC:PBIO) Dividends: History, Yield and DatesJanuary 16, 2024 | finance.yahoo.comPressure BioSciences’ New Consumer Products Unit Continues Long Sales Relationship with Dominant U.S. Retailer, Launching 2024 with Quarter Million Dollar Shipment in JanuaryJanuary 15, 2024 | benzinga.comToni Braxton Cheers PBIO's Acquisition Of Cannabis And Hemp Co. Uncle Bud'sJanuary 12, 2024 | theglobeandmail.comHemp-CBD Market Demand Gaining Momentum While Projected to Reach $16 Billion By 2025January 11, 2024 | markets.businessinsider.comPressure BioSciences To Acquire Uncle Bud's - Quick FactsJanuary 4, 2024 | finance.yahoo.comPressure BioSciences’ BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational (AI/ML) TechnologiesDecember 21, 2023 | finance.yahoo.comPressure BioSciences' Celebrates Second Groundbreaking Article Published This Month on its Transformative, Patented UltraShear Technology Processing PlatformDecember 12, 2023 | finance.yahoo.comPressure BioSciences’ UltraShear Platform Maintains Nutritional, Sensory, and Other Important Qualities of Liquid Foods While Inactivating Foodborne Bacterial SporesSee More Headlines Receive PBIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pressure BioSciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/17/2020Today5/03/2024Next Earnings (Estimated)5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Analytical instruments Sub-IndustryN/A Current SymbolOTCMKTS:PBIO CUSIPN/A CIK830656 Webwww.pressurebiosciences.com Phone508-230-1828Fax508-230-1829Employees16Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.69) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,080,000.00 Net Margins-1,050.11% Pretax Margin-1,050.15% Return on EquityN/A Return on Assets-1,272.67% Debt Debt-to-Equity RatioN/A Current Ratio0.03 Quick Ratio0.02 Sales & Book Value Annual Sales$1.73 million Price / Sales4.30 Cash FlowN/A Price / Cash FlowN/A Book Value($2.56) per share Price / Book-0.09Miscellaneous Outstanding Shares33,620,000Free Float29,989,000Market Cap$7.43 million OptionableNot Optionable Beta-0.20 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Richard T. Schumacher (Age 74)Founder, President, CEO, Treasurer, Interim CFO, Clerk & Director Comp: $320.54kDr. Edmund Y. Ting Ph.D. (Age 69)Sc.D. Ph.D., Senior Vice President of Engineering Comp: $215.16kDr. Alexander V. Lazarev Ph.D. (Age 59)Vice President of Research & Development Comp: $202.27kJohn B. HollisterDirector of Sales & MarketingKey CompetitorsPrecipioNASDAQ:PRPOTelesis BioNASDAQ:TBIOTalis BiomedicalNASDAQ:TLISAccelerate DiagnosticsNASDAQ:AXDXCue HealthNASDAQ:HLTHView All Competitors PBIO Stock Analysis - Frequently Asked Questions How have PBIO shares performed in 2024? Pressure BioSciences' stock was trading at $0.33 at the beginning of 2024. Since then, PBIO shares have decreased by 33.0% and is now trading at $0.2210. View the best growth stocks for 2024 here. Are investors shorting Pressure BioSciences? Pressure BioSciences saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 4,400 shares, a drop of 78.6% from the March 31st total of 20,600 shares. Based on an average trading volume of 104,100 shares, the days-to-cover ratio is presently 0.0 days. View Pressure BioSciences' Short Interest. When is Pressure BioSciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our PBIO earnings forecast. How were Pressure BioSciences' earnings last quarter? Pressure BioSciences, Inc. (OTCMKTS:PBIO) issued its quarterly earnings results on Tuesday, November, 17th. The company reported ($1.02) EPS for the quarter, beating analysts' consensus estimates of ($2.20) by $1.18. The company had revenue of $0.53 million for the quarter. Read the conference call transcript. What other stocks do shareholders of Pressure BioSciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pressure BioSciences investors own include Advanced Micro Devices (AMD), Allena Pharmaceuticals (ALNA), Actinium Pharmaceuticals (ATNM), Anavex Life Sciences (AVXL), Aware (AWRE), Curaleaf (CURLF) and Walt Disney (DIS). How do I buy shares of Pressure BioSciences? Shares of PBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PBIO) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pressure BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.